Document is current
Any future updates will be listed below
-
Authors
Foerster, Laura
Scholle, Leila
Mayer, Tobias
Schneider, Ilka
Stoltenburg-Didinger, Gisela
Delank, Karl-Stefan
Kraya, Torsten
Hahn, Andreas
Strube, David
Koelsch, Anna Katharina
Naegel, Steffen
Barba, Lorenzo
Volk, Alexander E.
Otto, Markus
Mensch, Alexander https://orcid.org/0000-0003-0089-4473
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (FTLDc 01GI1007A)
EU Joint Programme-Neurogenerative Diseases networks Genfi-Prox (01ED2008A)
EU (MOODMARKER 01EW2008)
Deutsche Forschungsgemeinschaft (SFB1279)
Baden-Württemberg Stiftung (D.3830)
Boehring Ingelheim Ulm University BioCenter (D.5009)
Fondation Thierry Latran
Medical Faculty of Martin-Luther-University Halle-Wittenberg (JCS24/02)
Martin-Luther-Universität Halle-Wittenberg
- License Information
-
More Information
Article History
Received: 15 October 2024
Revised: 11 January 2025
Accepted: 15 January 2025
First Online: 1 February 2025
Declarations
:
: AM has received speaking fees and advisory board honoraria from Hormosan and Sanofi, outside of the submitted work. All other authors report no conflicts of interest.
: This study was approved by the institutional research committee of Martin-Luther-University of Halle-Wittenberg (vote no. 2021–101). All subjects included in this study gave their informed consent.
